Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent.


Journal

Atherosclerosis
ISSN: 1879-1484
Titre abrégé: Atherosclerosis
Pays: Ireland
ID NLM: 0242543

Informations de publication

Date de publication:
11 2020
Historique:
received: 21 10 2019
revised: 12 08 2020
accepted: 13 08 2020
pubmed: 27 9 2020
medline: 24 6 2021
entrez: 26 9 2020
Statut: ppublish

Résumé

The impact of endothelial shear stress (ESS) on vessel remodeling in vessels implanted with bioresorbable scaffold (BRS) as compared to metallic drug-eluting stent (DES) remains elusive. The aim of this study was to determine whether the relationship between ESS and remodeling patterns differs in BRS from those seen in metallic DES at 3-year follow-up. In the ABSORB II randomized trial, lesions were investigated by serial coronary angiography and intravascular ultrasound (IVUS). Three-dimensional reconstructions of coronary arteries post-procedure and at 3 years were performed. ESS was quantified using non-Newtonian steady flow simulation. IVUS cross-sections in device segment were matched using identical landmarks. Paired ESS calculations post-procedure and at 3 years were feasible in 57 lesions in 56 patients. Post-procedure, median ESS at frame level was higher in BRS than in DES, with marginal statistical significance (0.97 ± 0.48 vs. 0.75 ± 0.39 Pa, p = 0.063). In the BRS arm, vessel area and lumen area showed larger increases in the highest tercile of median ESS post-procedure as compared to the lowest tercile. In contrast, in DES, no significant relationship between median ESS post-procedure and remodeling was observed. In multivariate analysis, smaller vessel area, larger lumen area, higher plaque burden post-procedure, and higher median ESS post-procedure were independently associated with expansive remodeling in matched frames. Only in BRS, younger age was an additional significant predictor of expansive remodeling. In a subset of lesions with large plaque burden, shear stress could be associated with expansive remodeling and late lumen enlargement in BRS, while ESS had no impact on vessel dimension in metallic DES.

Sections du résumé

BACKGROUND AND AIMS
The impact of endothelial shear stress (ESS) on vessel remodeling in vessels implanted with bioresorbable scaffold (BRS) as compared to metallic drug-eluting stent (DES) remains elusive. The aim of this study was to determine whether the relationship between ESS and remodeling patterns differs in BRS from those seen in metallic DES at 3-year follow-up.
METHODS
In the ABSORB II randomized trial, lesions were investigated by serial coronary angiography and intravascular ultrasound (IVUS). Three-dimensional reconstructions of coronary arteries post-procedure and at 3 years were performed. ESS was quantified using non-Newtonian steady flow simulation. IVUS cross-sections in device segment were matched using identical landmarks.
RESULTS
Paired ESS calculations post-procedure and at 3 years were feasible in 57 lesions in 56 patients. Post-procedure, median ESS at frame level was higher in BRS than in DES, with marginal statistical significance (0.97 ± 0.48 vs. 0.75 ± 0.39 Pa, p = 0.063). In the BRS arm, vessel area and lumen area showed larger increases in the highest tercile of median ESS post-procedure as compared to the lowest tercile. In contrast, in DES, no significant relationship between median ESS post-procedure and remodeling was observed. In multivariate analysis, smaller vessel area, larger lumen area, higher plaque burden post-procedure, and higher median ESS post-procedure were independently associated with expansive remodeling in matched frames. Only in BRS, younger age was an additional significant predictor of expansive remodeling.
CONCLUSIONS
In a subset of lesions with large plaque burden, shear stress could be associated with expansive remodeling and late lumen enlargement in BRS, while ESS had no impact on vessel dimension in metallic DES.

Identifiants

pubmed: 32979635
pii: S0021-9150(20)30495-0
doi: 10.1016/j.atherosclerosis.2020.08.031
pii:
doi:

Substances chimiques

Everolimus 9HW64Q8G6G

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-89

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Erhan Tenekecioglu (E)

Department of Interventional Cardiology, Erasmus University Medical Center. Thoraxcenter, Rotterdam, the Netherlands.

Yuki Katagiri (Y)

Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Kuniaki Takahashi (K)

Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Mariusz Tomaniak (M)

Department of Interventional Cardiology, Erasmus University Medical Center. Thoraxcenter, Rotterdam, the Netherlands; First Department of Cardiology, Medical University of Warsaw, Warsaw, Poland.

Dariusz Dudek (D)

Department of Interventional Cardiology, Jagiellonian University, Krakow, Poland.

Angel Cequier (A)

Bellvitge University Ho^spital, Barcelona, Spain.

Didier Carrié (D)

Hopital de Rangueil, Toulouse, France.

Andrés Iñiguez (A)

Interventional Cardiology Unit, Cardiology Department, Hospital Alvaro Cunqueiro, University Hospital of Vigo, Vigo, Spain.

Rinse Johannes van der Schaaf (R)

Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.

Marcello Dominici (M)

S Maria University Hospital, Terni, Italy.

Ad J van Boven (AJV)

Medical Center Leeuwarden, Leeuwarden, the Netherlands.

Steffen Helqvist (S)

Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Manel Sabaté (M)

Biomédiques August Pi I Sunyer, University of Barcelona, Barcelona, Spain.

Andreas Baumbach (A)

Bristol Heart Institute, Bristol, United Kingdom.

Jan J Piek (JJ)

Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Joanna J Wykrzykowska (JJ)

Department of Cardiology Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.

Pieter Kitslaar (P)

LKEB-Division of Image Processing, Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands.

Jouke Dijkstra (J)

LKEB-Division of Image Processing, Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands.

Johan H C Reiber (JHC)

LKEB-Division of Image Processing, Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands.

Bernard Chevalier (B)

Ramsay Générale de Santé, Institut Cardiovasculaire Paris Sud, Massy, France.

Dilek Ural (D)

Department of Cardiology, Koç University, Istanbul, Turkey.

Kerem Pekkan (K)

Department of Mechanical Engineering, Koç University, Istanbul, Turkey.

Christos V Bourantas (CV)

Department of Cardiology, University College of London Hospitals, London, United Kingdom; Department of Cardiology, Barts Heart Centre, London, United Kingdom.

Frank Gijsen (F)

Department of Biomedical Engineering, Erasmus University Medical Center, Thoraxcenter, Rotterdam, the Netherlands.

Yoshinobu Onuma (Y)

Department of Interventional Cardiology, Erasmus University Medical Center. Thoraxcenter, Rotterdam, the Netherlands.

Ryo Torii (R)

Department of Mechanical Engineering, University College London, United Kingdom.

Patrick W Serruys (PW)

Imperial College London, London, United Kingdom; Department of cardiology, National University of Ireland, Galway (NUIG), Galway, Ireland. Electronic address: patrick.w.j.c.serruys@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH